SCCM Resource Library-Pre-Cardiopulmonary Bypass Biomarkers Predict Poor Outcomes in Neonatal Congenital Heart Disease

Pre-Cardiopulmonary Bypass Biomarkers Predict Poor Outcomes in Neonatal Congenital Heart Disease

Video Transcription

Video Summary

Dr. Monique Gardner, a pediatric cardiac intensivist at the Children's Hospital of Philadelphia, discusses the need to identify patients at risk for poor outcomes after neonatal cardiopulmonary bypass surgery. Currently, risk factors are limited to non-modifiable factors such as demographics and type of cardiac disease. Dr. Gardner's research focuses on using preoperative biomarkers to assess risk. She performed a study measuring 28 biomarkers in neonates with congenital heart disease and found that 7 biomarkers were significantly associated with poor outcomes. However, more research is needed to validate these findings and understand their implications for prognosis and targeted therapies.

Asset Subtitle

Cardiovascular, Pediatrics, 2023

Asset Caption

Type: star research | Star Research Presentations: Biomarkers II, Pediatrics (SessionID 30008)

Meta Tag

Content Type Presentation

Knowledge Area Cardiovascular

Knowledge Area Pediatrics

Membership Level Professional

Membership Level Select

Tag Pediatrics

Tag Congenital Heart Disease

Year 2023

Keywords

Dr. Monique Gardner

pediatric cardiac intensivist

neonatal cardiopulmonary bypass surgery

preoperative biomarkers

poor outcomes

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.